{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:54:55Z","timestamp":1774054495352,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T00:00:00Z","timestamp":1370563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00296-013-2792-2","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T08:28:24Z","timestamp":1370507304000},"page":"2631-2635","source":"Crossref","is-referenced-by-count":16,"title":["Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study"],"prefix":"10.1007","volume":"33","author":[{"given":"Omer Nuri","family":"Pamuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum Emel","family":"Pamuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sayarlioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Donmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,7]]},"reference":[{"key":"2792_CR1","first-page":"1323","volume":"18","author":"J Sany","year":"1991","unstructured":"Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures JP (1991) Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol 18:1323\u20131327","journal-title":"J Rheumatol"},{"key":"2792_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780350203","volume":"35","author":"JM Kremer","year":"1992","unstructured":"Kremer JM, Phelps CT (1992) Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90\u00a0months. Arthritis Rheum 35:138\u2013145","journal-title":"Arthritis Rheum"},{"key":"2792_CR3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/ard.54.9.708","volume":"54","author":"GS Alarc\u00f3n","year":"1995","unstructured":"Alarc\u00f3n GS, Tracy IC, Strand GM, Singh K, Macaluso M (1995) Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. Ann Rheum Dis 54:708\u2013712","journal-title":"Ann Rheum Dis"},{"key":"2792_CR4","first-page":"S65","volume":"28","author":"Y Yazici","year":"2010","unstructured":"Yazici Y (2010) Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 28:S65\u2013S67","journal-title":"Clin Exp Rheumatol"},{"key":"2792_CR5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100\u20131104","journal-title":"Ann Rheum Dis"},{"key":"2792_CR6","first-page":"CD000957","volume":"2","author":"ME Suarez-Almazor","year":"2000","unstructured":"Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P (2000) Methotrexate for rheumatoid arthritis. Review. Cochrane Database Syst Rev 2:CD000957","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2792_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/anr.1780320603","volume":"32","author":"GS Alarc\u00f3n","year":"1989","unstructured":"Alarc\u00f3n GS, Tracy IC, Blackburn WD Jr (1989) Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32(6):671\u2013676","journal-title":"Arthritis Rheum"},{"key":"2792_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2008.106617","volume":"69","author":"SM Verstappen","year":"2010","unstructured":"Verstappen SM, Bakker MF, Heurkens AH et al (2010) Utrecht rheumatoid arthritis cohort study group. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 69:1044\u20131048","journal-title":"Ann Rheum Dis"},{"key":"2792_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2792_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein S, Mc Hugh PR (1975) \u2018Mini Mental State\u2019 a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189\u2013198","journal-title":"J Psychiatry Res"},{"key":"2792_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/ajp.148.1.102","volume":"148","author":"DW Molloy","year":"1991","unstructured":"Molloy DW, Alemayehu E, Roberts R (1991) Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am J Psychiatry 148:102\u2013105","journal-title":"Am J Psychiatry"},{"key":"2792_CR12","first-page":"273","volume":"13","author":"C G\u00fcngen","year":"2002","unstructured":"G\u00fcngen C, Ertan T, Eker E, Ya\u015far R, Engin F (2002) Reliability and validity of the standardized mini mental state examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg 13:273\u2013281 (Article in Turkish)","journal-title":"Turk Psikiyatri Derg"},{"key":"2792_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gps.2736","volume":"27","author":"TW Friedman","year":"2011","unstructured":"Friedman TW, Yelland GW, Robinson SR (2011) Subtle cognitive impairment in elders with mini-mental state examination scores within the \u2018normal\u2019 range. Int J Geriatr Psychiatry 27:463\u2013471","journal-title":"Int J Geriatr Psychiatry"},{"key":"2792_CR14","first-page":"280","volume":"8","author":"O Aydemir","year":"1997","unstructured":"Aydemir O (1997) Hastane anksiyete ve depresyon \u00f6l\u00e7e\u011fi T\u00fcrk\u00e7e formunun ge\u00e7erlilik ve g\u00fcvenilirlik \u00e7al\u0131\u015fmas\u0131. T\u00fcrk Psikiyatri Dergisi 8:280\u2013287 (Article in Turkish)","journal-title":"T\u00fcrk Psikiyatri Dergisi"},{"key":"2792_CR15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00296-011-2041-5","volume":"31","author":"H Al-Hasani","year":"2011","unstructured":"Al-Hasani H, Roussou E (2011) Methotrexate for rheumatoid arthritis patients who are on hemodialysis. Rheumatol Int 31:1545\u20131547","journal-title":"Rheumatol Int"},{"key":"2792_CR16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10067-006-0407-y","volume":"26","author":"A Isik","year":"2007","unstructured":"Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872\u2013878","journal-title":"Clin Rheumatol"},{"key":"2792_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.20474","volume":"51","author":"MM VanDyke","year":"2004","unstructured":"VanDyke MM, Parker JC, Smarr KL et al (2004) Anxiety in rheumatoid arthritis. Arthritis Rheum 51:408\u2013412","journal-title":"Arthritis Rheum"},{"key":"2792_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3899\/jrheum.080576","volume":"36","author":"MC Fisher","year":"2009","unstructured":"Fisher MC, Cronstein BN (2009) Metaanalysis of methylene tetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J Rheumatol 36:539\u2013545","journal-title":"J Rheumatol"},{"key":"2792_CR19","first-page":"572","volume":"35","author":"P Ranganathan","year":"2008","unstructured":"Ranganathan P, Culverhouse R, Marsh S et al (2008) Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 35:572\u2013579","journal-title":"J Rheumatol"},{"key":"2792_CR20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00296-012-2494-1","volume":"33","author":"E Efrati","year":"2013","unstructured":"Efrati E, Elkin H, Nahum S, Krivoy N (2013) Population distribution of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C risk alleles for methotrexate toxicity in Israel. Rheumatol Int 33:1001\u20131004","journal-title":"Rheumatol Int"},{"key":"2792_CR21","first-page":"979","volume":"35","author":"OA Malysheva","year":"2008","unstructured":"Malysheva OA, Wahle M, Wagner U, Pierer M, Arnold S, H\u00e4ntzschel H, Baerwald CG (2008) Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. J Rheumatol 35:979\u2013985","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2792-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2792-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2792-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:47Z","timestamp":1559028107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2792-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,7]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2792-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,7]]}}}